Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
590,231,680
-
Number of holders
-
684
-
Total 13F shares, excl. options
-
179,067,536
-
Shares change
-
-1,640,794
-
Total reported value, excl. options
-
$17,857,436,721
-
Value change
-
-$88,134,950
-
Put/Call ratio
-
57.45%
-
Number of buys
-
336
-
Number of sells
-
-289
-
Price
-
$99.73
Significant Holders of Edwards Lifesciences Corp - Common Stock (EW) as of Q2 2016
760 filings reported holding EW - Edwards Lifesciences Corp - Common Stock as of Q2 2016.
Edwards Lifesciences Corp - Common Stock (EW) has 684 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 179,067,536 shares
of 590,231,680 outstanding shares and own 30.34% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (18,796,184 shares), FMR LLC (12,366,588 shares), SANDS CAPITAL MANAGEMENT, LLC (9,619,255 shares), STATE STREET CORP (8,628,238 shares), Capital Research Global Investors (6,647,014 shares), BlackRock Institutional Trust Company, N.A. (5,460,928 shares), AMERIPRISE FINANCIAL INC (4,253,976 shares), BlackRock Fund Advisors (4,194,236 shares), FRANKLIN RESOURCES INC (3,158,218 shares), and Voya Investment Management LLC (2,687,048 shares).
This table shows the top 684 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.